The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study

Background/Aim: Radium-223 dichloride (²²³RaCl₂) represents a therapeutic option for metastatic castration-resistant prostate cancer (mCRPC) patients dealing with symptomatic bone metastases. The identification of baseline variables potentially affecting the life-prolonging rol...

Description complète

Détails bibliographiques

Auteurs principaux:	Maria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, Alessio Farcomeni, Luca Filippi, Elisa Lodi Rizzini, Valentina Lavelli, Maria Lina Stazza, Tania Di Raimondo, Giuseppe Fornarini, Sara Elena Rebuzzi, Mammini Filippo, Paolo Mammucci, Andrea Marongiu, Fabio Monari, Giuseppe Rubini, Angela Spanu, Giuseppe De Vincentis
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-04-01
Collection:	Biomedicines
Sujets:	mCRPC DASciS software bone scan index radium-223 overall survival bone metastasis
Accès en ligne:	https://www.mdpi.com/2227-9059/11/4/1103
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!